Multiple Vaccines and Strategies for Pandemic Preparedness of Avian Influenza Virus.

Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium: Internet ISSN: 1999-4915 (Electronic) Linking ISSN: 19994915 NLM ISO Abbreviation: Viruses Subsets: MEDLINE

Original Publication: Basel, Switzerland : MDPI

Influenza in Birds*/prevention & control ; COVID-19* ; Vaccines* ; Influenza A virus*; Animals ; Humans ; Pandemics/prevention & control ; Disease Outbreaks

Avian influenza viruses (AIV) are a continuous cause of concern due to their pandemic potential and devasting effects on poultry, birds, and human health. The low pathogenic avian influenza virus has the potential to evolve into a highly pathogenic avian influenza virus, resulting in its rapid spread and significant outbreaks in poultry. Over the years, a wide array of traditional and novel strategies has been implemented to prevent the transmission of AIV in poultry. Mass vaccination is still an economical and effective approach to establish immune protection against clinical virus infection. At present, some AIV vaccines have been licensed for large-scale production and use in the poultry industry; however, other new types of AIV vaccines are currently under research and development. In this review, we assess the recent progress surrounding the various types of AIV vaccines, which are based on the classical and next-generation platforms. Additionally, the delivery systems for nucleic acid vaccines are discussed, since these vaccines have attracted significant attention following their significant role in the fight against COVID-19. We also provide a general introduction to the dendritic targeting strategy, which can be used to enhance the immune efficiency of AIV vaccines. This review may be beneficial for the avian influenza research community, providing ideas for the design and development of new AIV vaccines.

Dev Biol Stand. 1999;98:127-32; discussion 133-4. (PMID: 10494965)
Avian Dis. 2000 Jan-Mar;44(1):132-7. (PMID: 10737653)
PLoS One. 2009 Jun 24;4(6):e6032. (PMID: 19554101)
Iran Red Crescent Med J. 2013 Jan;15(1):75-82. (PMID: 23487492)
Pharmaceutics. 2021 Aug 31;13(9):. (PMID: 34575445)
J Infect Dis. 2001 May 1;183(9):1395-8. (PMID: 11294672)
Immunol Cell Biol. 2001 Dec;79(6):537-46. (PMID: 11903613)
Front Microbiol. 2020 Aug 14;11:1961. (PMID: 32922379)
Vaccine. 2017 Sep 12;35(38):5115-5122. (PMID: 28822642)
Virus Res. 2013 Dec 5;178(1):44-52. (PMID: 23735534)
Int J Nanomedicine. 2022 Apr 05;17:1593-1608. (PMID: 35411142)
Small. 2021 Apr;17(13):e2007214. (PMID: 33682339)
Int J Nanomedicine. 2018 Nov 23;13:7959-7970. (PMID: 30538470)
Front Vet Sci. 2021 Nov 11;8:774630. (PMID: 34859093)
Virology. 2003 Feb 1;306(1):18-24. (PMID: 12620793)
Viruses. 2019 Mar 26;11(3):. (PMID: 30917500)
Expert Rev Vaccines. 2017 Feb;16(2):123-136. (PMID: 27653543)
Biomaterials. 2010 Mar;31(8):2425-34. (PMID: 20034662)
Br Med Bull. 2019 Dec 11;132(1):81-95. (PMID: 31848585)
Vaccine. 2003 Jan 30;21(7-8):644-8. (PMID: 12531333)
Vet Res. 2019 Oct 10;50(1):78. (PMID: 31601266)
J Anim Sci. 2012 Jul;90(7):2246-54. (PMID: 22247115)
Microb Cell Fact. 2011 Aug 30;10 Suppl 1:S4. (PMID: 21995317)
J Trauma. 2006 Mar;60(3):655-8. (PMID: 16531872)
Nat Med. 2021 Jan;27(1):106-114. (PMID: 33288923)
Carbohydr Polym. 2018 Oct 15;198:131-141. (PMID: 30092983)
Vaccine. 2015 Sep 11;33(38):4807-12. (PMID: 26241952)
Adv Immunol. 2005;86:241-305. (PMID: 15705424)
Viruses. 2022 Dec 30;15(1):. (PMID: 36680158)
Front Pharmacol. 2015 Dec 01;6:286. (PMID: 26648870)
PLoS One. 2012;7(11):e48750. (PMID: 23144954)
Vaccine. 2017 Feb 1;35(5):738-746. (PMID: 28065477)
Int J Nanomedicine. 2017 Jul 31;12:5443-5460. (PMID: 28814862)
Arch Pharm Res. 2003 Jun;26(6):493-8. (PMID: 12877561)
Curr Issues Mol Biol. 2017;22:129-138. (PMID: 27831541)
Curr Opin Microbiol. 2013 Feb;16(1):17-22. (PMID: 23290772)
Drug Discov Today. 2021 Nov;26(11):2575-2592. (PMID: 34214667)
Vaccines (Basel). 2021 Apr 07;9(4):. (PMID: 33916924)
J Biomed Sci. 2019 Oct 19;26(1):76. (PMID: 31629405)
Langmuir. 2019 Apr 2;35(13):4613-4625. (PMID: 30840475)
Avian Dis. 2016 May;60(1 Suppl):232-7. (PMID: 27309060)
J Virol. 2005 Sep;79(17):11014-21. (PMID: 16103152)
J Biol Chem. 2011 Oct 21;286(42):36198-214. (PMID: 21868382)
Hum Vaccin Immunother. 2017 Jan 2;13(1):111-116. (PMID: 27648636)
Viruses. 2017 Aug 21;9(8):. (PMID: 28825679)
Vaccine. 2008 Sep 12;26 Suppl 4:D41-4. (PMID: 19230158)
J Virol. 2018 Jan 2;92(2):. (PMID: 29118117)
Appl Microbiol Biotechnol. 2015 Apr;99(7):2967-77. (PMID: 25750046)
mBio. 2019 May 21;10(3):. (PMID: 31113896)
Nat Commun. 2018 Aug 22;9(1):3361. (PMID: 30135514)
Vaccine. 2003 Sep 8;21(25-26):4036-42. (PMID: 12922140)
Transbound Emerg Dis. 2020 Jul;67(4):1463-1471. (PMID: 32065513)
J Immunol. 2019 Jan 15;202(2):392-398. (PMID: 30617121)
Vaccine. 2015 Feb 25;33(9):1197-205. (PMID: 25613723)
Biochim Biophys Acta. 1998 Mar 13;1370(2):259-72. (PMID: 9545576)
Expert Rev Vaccines. 2012 Jun;11(6):695-719. (PMID: 22873127)
Enferm Infecc Microbiol Clin (Engl Ed). 2023 May;41(5):301-304. (PMID: 35906174)
Avian Pathol. 2004 Aug;33(4):405-12. (PMID: 15370037)
Cell Res. 2017 Dec;27(12):1409-1421. (PMID: 29151586)
Microbes Infect. 2016 Apr;18(4):237-44. (PMID: 26655884)
Avian Dis. 1997 Oct-Dec;41(4):856-63. (PMID: 9454919)
Avian Pathol. 1974 Jan;3(1):15-24. (PMID: 18777253)
Parasit Vectors. 2014 Mar 31;7:145. (PMID: 24685150)
J Immunol. 2016 Nov 1;197(9):3575-3585. (PMID: 27671110)
Vaccines (Basel). 2021 Jun 16;9(6):. (PMID: 34208489)
Vet Microbiol. 2017 Jul;206:144-151. (PMID: 27916319)
Curr Opin Immunol. 2018 Aug;53:96-101. (PMID: 29730560)
J Immunol. 2011 Jan 15;186(2):1022-31. (PMID: 21169548)
Pediatrics. 2019 Feb;143(2):. (PMID: 30617239)
Nanomedicine. 2014 May;10(4):775-82. (PMID: 24361386)
Med Sci (Basel). 2018 Mar 23;6(2):. (PMID: 29570602)
J Immunol. 2014 Nov 1;193(9):4335-43. (PMID: 25246496)
Nat Rev Drug Discov. 2020 Apr;19(4):239-252. (PMID: 32060419)
Expert Rev Vaccines. 2014 Dec;13(12):1537-51. (PMID: 25308708)
Int J Mol Sci. 2017 Jul 11;18(7):. (PMID: 28696399)
Viruses. 2016 Nov 23;8(11):. (PMID: 27886076)
Avian Pathol. 2003 Feb;32(1):25-32. (PMID: 12745375)
Infect Immun. 2002 Apr;70(4):1915-23. (PMID: 11895955)
Expert Opin Biol Ther. 2014 Dec;14(12):1801-13. (PMID: 25145964)
Expert Rev Vaccines. 2016;15(3):313-29. (PMID: 26707950)
Acta Biochim Pol. 2014;61(3):515-22. (PMID: 25210719)
Emerg Microbes Infect. 2022 Dec;11(1):1174-1185. (PMID: 35380505)
Antiviral Res. 2007 Sep;75(3):234-41. (PMID: 17451817)
Vaccine. 2019 Nov 8;37(47):7003-7010. (PMID: 31047676)
Vaccines (Basel). 2013 Jun 25;1(3):225-49. (PMID: 26344110)
Results Immunol. 2012 Dec 03;3:1-9. (PMID: 24600553)
Proc Natl Acad Sci U S A. 2022 Mar 29;119(13):e2025607119. (PMID: 35320040)
PLoS One. 2012;7(1):e30898. (PMID: 22303469)
Clin Vaccine Immunol. 2017 Jan 5;24(1):. (PMID: 27847366)
Virol J. 2010 Jul 14;7:157. (PMID: 20630098)
J Drug Deliv. 2013;2013:869718. (PMID: 24228179)
Mol Ther Methods Clin Dev. 2016 Dec 24;4:83-91. (PMID: 28344994)
Emerg Microbes Infect. 2013 Aug;2(8):e52. (PMID: 26038486)
Appl Microbiol Biotechnol. 2011 Feb;89(4):893-902. (PMID: 21063703)
Vaccines (Basel). 2021 Jan 28;9(2):. (PMID: 33525396)
Front Immunol. 2021 Jul 13;12:711997. (PMID: 34326849)
PLoS One. 2011;6(11):e27605. (PMID: 22110686)
Vaccine. 2013 Nov 19;31(48):5754-9. (PMID: 24012571)
Signal Transduct Target Ther. 2021 Aug 4;6(1):291. (PMID: 34344870)
Eur J Immunol. 1993 Jul;23(7):1719-22. (PMID: 8325342)
Virol J. 2016 Aug 26;13(1):143. (PMID: 27562235)
Curr Top Microbiol Immunol. 2009;333:153-62. (PMID: 19768404)
Int J Biol Macromol. 2020 Aug 1;156:928-937. (PMID: 32289420)
J Virol. 2016 Oct 14;90(21):9797-9805. (PMID: 27558424)
Transbound Emerg Dis. 2020 Apr 7;:. (PMID: 32259345)
J Med Virol. 2022 Jun;94(6):2578-2587. (PMID: 35171514)
Virus Res. 2015 Jun 2;204:40-6. (PMID: 25892718)
Biochim Biophys Acta. 2000 Jul 3;1475(2):125-32. (PMID: 10832026)
Viruses. 2019 Jul 05;11(7):. (PMID: 31284485)
J Control Release. 2017 Nov 10;265:66-74. (PMID: 28434892)
Vaccine. 1999 Dec 10;18(9-10):765-77. (PMID: 10580187)
Trends Microbiol. 2020 Jan;28(1):57-67. (PMID: 31629602)
Proc Natl Acad Sci U S A. 2005 Dec 13;102(50):18141-6. (PMID: 16330777)
Front Microbiol. 2021 Feb 04;11:613437. (PMID: 33613465)
Adv Colloid Interface Sci. 2018 Mar;253:117-140. (PMID: 29454463)
Emerg Microbes Infect. 2023 Dec;12(1):2155072. (PMID: 36458831)
Angew Chem Int Ed Engl. 2021 Jun 7;60(24):13225-13243. (PMID: 32893932)
Viruses. 2020 Sep 17;12(9):. (PMID: 32957468)
Am J Trop Med Hyg. 2018 Mar;98(3):849-856. (PMID: 29363446)
Proc Natl Acad Sci U S A. 2015 Jun 23;112(25):7809-14. (PMID: 26056267)
Braz J Microbiol. 2015 Mar 04;45(4):1117-29. (PMID: 25763014)
J Virol. 2014 Jun;88(12):6959-69. (PMID: 24719412)
Vaccine. 2011 Jun 24;29(29-30):4761-70. (PMID: 21565240)
Nat Commun. 2020 Nov 20;11(1):5909. (PMID: 33219213)
J Virol. 2007 Jan;81(1):150-8. (PMID: 17050610)
Front Immunol. 2021 Aug 31;12:710647. (PMID: 34531860)
Rev Sci Tech. 2009 Apr;28(1):267-74. (PMID: 19618631)
Expert Rev Vaccines. 2010 Jan;9(1):59-72. (PMID: 20021306)
Vaccines (Basel). 2020 Nov 19;8(4):. (PMID: 33227887)
PLoS One. 2008 Jan 30;3(1):e1501. (PMID: 18231588)
J Infect Dis. 2019 Apr 8;219(Suppl_1):S62-S67. (PMID: 30715353)
PLoS One. 2011;6(7):e22549. (PMID: 21818336)
Vaccine. 2019 Sep 3;37(37):5567-5577. (PMID: 31399277)
J Med Virol. 2014 May;86(5):886-94. (PMID: 24122866)
Vaccines (Basel). 2020 Aug 03;8(3):. (PMID: 32756443)
J Transl Med. 2005 Dec 29;3:45. (PMID: 16384534)

Keywords: avian influenza virus; delivery system; immune response; prevention; vaccine

0 (Vaccines)

Date Created: 20230826 Date Completed: 20230828 Latest Revision: 20230907

20240628

PMC10459121

10.3390/v15081694

37632036